HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Iloprost ameliorates post-ischemic lung reperfusion injury and maintains an appropriate pulmonary ET-1 balance.

AbstractBACKGROUND:
Ischemia-reperfusion (I/R) injury of the lung involves increased pulmonary vascular resistance. Prostaglandins are thought to have a beneficial effect in lung transplantation, but their mechanism in I/R injury is unknown. We investigated whether iloprost, a stable prostacyclin analogue, prevents I/R-associated pulmonary vascular dysfunction and whether it affects endothelin-1 (ET-1) balance.
METHODS:
In an isolated blood-perfusion model, we subjected lungs of Lewis rats to 45 minutes of ischemia at 37 degrees C and randomly allocated the lungs to 3 groups (n = 6 each): iloprost (33.3 nmol/liter) added to the perfusate before ischemia and reperfusion (ILO+IR), iloprost (33.3 nmol/liter) given only before reperfusion (ILO+R), and controls without iloprost treatment (ILO-).
RESULTS:
Reperfusion induced marked pulmonary edema in non-treated controls (ILO-), which was attenuated in ILO+R lungs and completely prevented in ILO+IR lungs. At 60 minutes reperfusion, arterial oxygen tension was significantly greater in both ILO+R and ILO+IR lungs compared with ILO- controls. Mean pulmonary artery pressure and pulmonary vascular resistance were slightly decreased in the ILO+R and significantly decreased in the ILO+IR group compared with the ILO- controls. Plasma levels of big ET-1, measured in both afferent and efferent blood, showed that I/R results in increased pulmonary venous levels of big ET-1. Interestingly, the increased venoarterial ET-1 gradient in ILO- lungs decreased significantly in the ILO+IR group.
CONCLUSIONS:
We demonstrated in an isolated lung perfusion model that iloprost ameliorates post-ischemic lung reperfusion injury and maintains an appropriate pulmonary ET-1 balance.
AuthorsMasahiro Kawashima, Takayuki Nakamura, Sven Schneider, Brigitte Vollmar, Henning F Lausberg, Michael Bauer, Michael D Menger, Hans-Joachim Schäfers
JournalThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (J Heart Lung Transplant) Vol. 22 Issue 7 Pg. 794-801 (Jul 2003) ISSN: 1053-2498 [Print] United States
PMID12873548 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Endothelin-1
  • Vasodilator Agents
  • Iloprost
  • Oxygen
Topics
  • Animals
  • Body Weight
  • Disease Models, Animal
  • Endothelin-1 (drug effects, metabolism)
  • Iloprost (pharmacology)
  • Lung (drug effects, metabolism, physiopathology)
  • Male
  • Models, Cardiovascular
  • Oxygen (blood)
  • Pulmonary Circulation (drug effects)
  • Pulmonary Edema (metabolism, physiopathology)
  • Pulmonary Gas Exchange (drug effects)
  • Pulmonary Wedge Pressure (drug effects)
  • Rats
  • Rats, Inbred Lew
  • Reperfusion Injury (metabolism, physiopathology)
  • Respiratory Distress Syndrome (metabolism, physiopathology)
  • Severity of Illness Index
  • Statistics as Topic
  • Vascular Resistance (drug effects)
  • Vasodilator Agents (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: